Effects of terbutaline and budesonide on sputum cells and bronchial hyperresponsiveness in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 5, 2000, Pages 1459-1464

  Aldridce, Ruth E ^a   Hancox, Robert J ^a   Taylor, D Robin ^a   Cowan, Jan O ^a   Winn, Marti C ^a   Frampton, Chris M ^a   Town, G Ian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; TERBUTALINE;

ADOLESCENT; ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS BIOPSY; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE DIFFERENTIAL COUNT; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS; TURBUHALER;

EID: 0034027301     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.5.9906052     Document Type: Article

References (31)

1. 1. Barnes, P. J. 1998. Efficacy of inhaled corticosleroids in asthma. J. Allergy Clin. Immunol. 102:531-538.
2. 2. Sears, M. R., and D. R. Taylor. 1994. The beta 2-agonist controversy: observations, explanations and relationship to asthma epidemiology. Drug Safely 11:259-283.
3. 3. Taylor, D. R., M. R. Sears, and D. W. Cockcroft. 1996. The β-agonist controversy. Med. Clin. North Am. 80:719-748.
4. 4. Cockcroft, D. W., and V. A. Swystun. 1996. Functional antagonism: tolerance produced by inhaled heta-2 agonists. Thorax 51:1051-1056.
5. 5. Barrett, T. E., and B. L. Strom. 1995. Inhaled beta-adrenergic receptor agonists in asthma: more harm than good? Am. J. Respir. Crit. Care Med. 151:574-577.
6. 6. O'Connor, B. J., S. L. Aikman, and P. J. Barnes. 1992. Tolerance to the non-bronchodilator effects of inhaled beta 2-agonists in asthma. N. Engl. J. Med. 327:1204-1208.
7. 7. Taylor, D. A., M. W. Jensen, S. L. Aikman, J. G. Harris, P. J. Barnes, and B. J. O'Connor. 1997. Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am. J. Respir. Crit. Care Med. 156:1731-1737.
8. 8. Cockcroft, D. W., V. A. Swystun, and R. Bhagat. 1995. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine. Am. J. Respir. Crit. Cure Med. 152: 1485-1489.
9. 9. Cockcroft, D. W., C. P. McParland, S. A. Britto, V. A. Swystun, and B. C. Rutherford. 1993. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342:833-837.
10. 10. Bhagat, R., V. A. Swystun, and D. W. Cockcroft. 1996. Salbutamol-induced increased airway responsiveness to allergen and reduced protection versus methacholine: dose response. J. Allergy Clin. Immunol. 97:47-52.
11. 11. Manolitsas, N. D., J. Wang, J. L. Devalia, C. J. Trigg, A. E. McAulay, and R. J. Davies. 1995. Regular albuterol, nedocromil sodium, and bronchial inflammation in asthma. Am. J. Respir. Crit. Care Med. 151:1925-1930.
12. 12. Adelroth, E., L. Rosenhall, S. A. Johansson, M. Linden, and P. Venge. 1990. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage: the effects of antiasthmatic treatment with budesonide or terbutaline. Am. Rev. Respir. Dis. 142:91-99.
13. 13. Laitinen, L. A., A. Laitinen, and T. Haahtela. 1992. A comparative study of the effects of an inhaled corticosteroid, budesonide, and a beta-2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial. J. Allergy Clin. Immunol. 90:32-42.
14. 14. Adcock, I. M., D. A. Stevens, P. J. Barnes. 1996. Interactions of glucocorticoids and beta 2 agonists. Eur. Respir. J. 9:160-168.
15. 15. Wong. C. S., I. Wahedna, I. D. Pavord, and A. E. Tattersfield. 1994. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge. Am. J. Respir. Crit. Care Med. 150:1268-1273.
16. 16. Hancox, R. J., J. O. Cowan, E. M. Flannery, G. P. Herbison, C. R. McLachlan, C. S. Wong, and D. R. Taylor. 1999. A randomized trial of inhaled β-agonist, inhaled corticosteroid and their combination in the treatment of asthma. Thorax 54:482-487.
17. 17. Iredale, M. J., S. A. R. Wanklyn, I. P. Phillips, T. Krausz, and P. W. Ind. 1994. Non-invasive assessment of bronchial inflammation in asthma: no correlation between eosinophilia of induced sputum and bronchial responsiveness to inhaled hypertonic saline. Clin. Exp. Allergy 24:940-945.
18. 18. Yan, K., C. Salome, and A. J. Woolcock. 1983. Rapid method for measurement of bronchial responsiveness. Thorax 38:760-765.
19. 19. Fahy, J. V., J. Liu, H. Wong, and H. A. Boushey. 1993. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am. Rev. Respir. Dis. 147:1126-1131.
20. 20. Gauvreau, G. M., M. Jordana, R. M. Watson, D. W. Cockroft, P. M. O'Byrne. 1997. Effect of regular inhaled albuterol on allergen-induced late responses and sputum eosinophils in asthmatic subjects. Am. J. Respir. Crit. Care Med. 156:1738-1745.
21. 21. Lai, C. K., O. P. Twentyman, and S. T. Holgate. 1989. The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness. Am. Rev. Respir. Dis. 140:917-923.
22. 22. Nielson, C. P., and N. E. Hadjokas. 1998. Beta-adrenoceptor agonists block corticosteroid inhibition in eosinophils. Am. J. Respir. Crit. Care Med. 57:184-191.
23. 23. Evans, D. W., C. M. Salome, G. G. King, S. J. Rimmer, J. P. Seale, and A. J. Woolcock. 1997. Effect of regular inhaled salbutamol on airway responsiveness and airway inflammation in rhinitic non-asthmatic subjects. Thorax 52:136-142.
24. 24. Smith, C. M., and S. D. Anderson. 1989. Inhalation provocation tests using nonisotonic aerosols. J. Allergy Clin. Immunol. 84:781-790.
25. 25. Juniper, E. F., P. A. Kline, M. A. Vanzieleghem, E. H. Ramsdale, P. M. O'Byrne, and F. E. Hargreave. 1990. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am. Rev. Respir. Dis. 142:832-836.
26. 26. Gauvreau, G. M., J. Doctor, R. M. Watson, M. Jordana, and P. M. O'Byrne. 1996. Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation. Am. J. Respir. Crit. Care Med. 154:1267-1271.
27. 27. Claman, D. M., H. A. Boushey, J. Liu, H. Wong, and J. V. Fahy. 1994. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J. Allergy Clin. Immunol. 94:861-869.
28. 28. Djukanovic, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma. Am. Rev. Respir. Dis. 145:669-674.
29. 29. Wilding. P. J., M. M. Clark, J. Oborne, J. A. Bennett, and A. E. Tattersfield. 1996. Effect of regular terbutaline on the airway response to inhaled budesonide. Thorax 51:989-992.
30. 30. Sears, M. R., D. R. Taylor, C. G. Print, D. C. Lake, E. M. Flannery, M. K. Lucas, D. M. Yates, G. P. Herbison, and Q. Li. 1990. Regular inhaled β-agonist treatment in bronchial asthma. Lancet 336:1391-1396.
31. 31. Taylor, D. R., M. R. Sears, G. P. Herbison, E. M. Flannery, C. G. Print, D. C. Lake, D. M. Yates, M. K. Lucas, and Q. Li. 1993. Regular inhaled β-agonist in asthma: effects on lung function and exacerbations. Thorax 48:134-138.